Loading...
Loading...
Application UK00909396755 · DO-NOT-DISPLAY
| Application Number | UK00909396755 |
| Status | DO-NOT-DISPLAY |
| Owner | Mitomics Inc. |
| Filed | 2010-09-23 |
| Registered | 2011-03-01 |
| Renewal Due | 2020-09-23 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
EMPOWERING CLINICAL INSIGHT has a current status of DO-NOT-DISPLAY.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Assay and test kits containing chemicals, reagents and nucleic acid or protein probes for prognosticating and diagnosing diseases and providing genomic and proteomic profiles useful in the selection of treatments for research laboratory and clinical medical uses.
Genetic testing for research laboratory and clinical medical purposes.
'EMPOWERING CLINICAL INSIGHT' is a do-not-display trademark on the UK IPO register, owned by Mitomics Inc.. The application (UK00909396755) was filed on 23 September 2010 and registered on 1 March 2011. The registration is set to expire on 23 September 2020.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 42 (scientific, IT & design services).
The trademark is represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB.
UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' in Class 1, 42 is recorded on the UK IPO register as owned by Mitomics Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' as do-not-display.
UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 42 (scientific, IT & design services). The filed specification reads: Class 1: Assay and test kits containing chemicals, reagents and nucleic acid or protein probes for prognosticating and diagnosing diseases and providing genomic and proteomic profiles useful in the selection of treatments for research laboratory and clinical medical uses. | Class 42: Genetic testing for research lab…
UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' was filed at the UK IPO on 23 September 2010 and registered on 1 March 2011.
UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' is currently recorded as valid until 23 September 2020, at which point it will need to be renewed with the UK IPO to remain in force.
UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB is listed as the attorney / representative of record for UK trademark UK00909396755 for the mark 'EMPOWERING CLINICAL INSIGHT' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "EMPOWERING CLINICAL INSIGHT" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| EMPOWERING CLINICAL INSIGHTSame applicant | 85136040 | 602 | 2010-09-22 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.